Development and Implementation of a Mobile Application for Choosing Empirical Antimicrobial Therapy for Bacteremia, Pneumonia, Urinary Tract Infection, and Skin and Soft Tissue Infection among Hospitalized Patients
dc.contributor.author | Chaloernpoj K. | |
dc.contributor.author | Wangchinda W. | |
dc.contributor.author | Koomanachai P. | |
dc.contributor.author | Thamlikitkul V. | |
dc.contributor.author | Rattanaumpawan P. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2023-05-19T07:46:53Z | |
dc.date.available | 2023-05-19T07:46:53Z | |
dc.date.issued | 2023-01-01 | |
dc.description.abstract | Clinical practice guidelines (CPGs) and computerized clinical decision support programs are effective antimicrobial stewardship strategies. The DigitalAMS™, a mobile-based application for choosing empirical antimicrobial therapy under the hospital’s CPGs, was implemented at Siriraj Hospital and evaluated. From January to June 2018, a cross-sectional study was conducted among 401 hospitalized adults who received ≥1 dose of antimicrobials and had ≥1 documented site-specific infection. The antimicrobial regimen prescribed by the ward physician (WARD regimen), recommended by the DigitalAMS™ (APP regimen), and recommended by two independent infectious disease (ID) physicians before (Emp-ID regimen) and after (Def-ID regimen) the final microbiological results became available were compared in a pairwise fashion. The percent agreement of antimicrobial prescribing between the APP and Emp-ID regimens was 85.7% in the bacteremia group, 59.1% in the pneumonia group, 78.6% in the UTI group, and 85.2% in the SSTI group. The percent agreement between the APP and Emp-ID regimens was significantly higher than that between the WARD and Emp-ID regimens in three site-specific infection groups: the bacteremia group (85.7% vs. 47.9%, p < 0.001), the UTI group (78.6% vs. 37.8%, p < 0.001), and the SSTI group (85.2% vs. 40.2%, p < 0.001). Furthermore, the percent agreement between the APP and Def-ID regimens was similar to that between the Emp-ID and Def-ID regimens in all sites of infection. In conclusions, the implementation of DigitalAMS™ seems useful but needs some revisions. The dissemination of this ready-to-use application with customized clinical practice guidelines to other hospital settings may be beneficial. | |
dc.identifier.citation | Antibiotics Vol.12 No.1 (2023) | |
dc.identifier.doi | 10.3390/antibiotics12010113 | |
dc.identifier.eissn | 20796382 | |
dc.identifier.scopus | 2-s2.0-85146443590 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/81979 | |
dc.rights.holder | SCOPUS | |
dc.subject | Immunology and Microbiology | |
dc.title | Development and Implementation of a Mobile Application for Choosing Empirical Antimicrobial Therapy for Bacteremia, Pneumonia, Urinary Tract Infection, and Skin and Soft Tissue Infection among Hospitalized Patients | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85146443590&origin=inward | |
oaire.citation.issue | 1 | |
oaire.citation.title | Antibiotics | |
oaire.citation.volume | 12 | |
oairecerif.author.affiliation | Siriraj Hospital |